<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">896</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>CURRENT TREATMENT PARADIGMS FOR RETINOBLASTOMA&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pandey</surname><given-names>Shanti</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pandey</surname><given-names>Kavita</given-names></name></contrib><contrib contrib-type="author"><name><surname>Joshi</surname><given-names>Vijay</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Swati</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kalpana</surname><given-names/></name></contrib></contrib-group><volume/><issue/><fpage>145</fpage><lpage>155</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Retinoblastoma is a primary malignant neoplasm of the retina that arises from immature retinal cells&#13;
which affects infants and children and it is the most common primary tumor of the eye in children.&#13;
Retinoblastoma detected on time can lead the child to see and moreover can save his life.&#13;
Retinoblastoma in later stages can endanger life. It becomes essential to know most about this life&#13;
threating as well as sight threating condition. Let these children live and enjoy the color of life.&#13;
</p></abstract><kwd-group><kwd>Retinoblastoma</kwd><kwd> chemotherapy</kwd><kwd> tumor</kwd><kwd> eye</kwd></kwd-group></article-meta></front></article>
